These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 21692821)

  • 21. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
    Rossi RE; Conte D; Massironi S
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.
    O'Toole A; Alakkari A; Keegan D; Doherty G; Mulcahy H; O'Donoghue D
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):439-41. PubMed ID: 22094024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Loftus EV; Harewood GC; Loftus CG; Tremaine WJ; Harmsen WS; Zinsmeister AR; Jewell DA; Sandborn WJ
    Gut; 2005 Jan; 54(1):91-6. PubMed ID: 15591511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
    Fausa O; Schrumpf E; Elgjo K
    Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
    Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer after orthotopic liver transplantation.
    Silva MA; Jambulingam PS; Mirza DF
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
    Ngu JH; Gearry RB; Wright AJ; Stedman CA
    Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
    Rudolph G; Gotthardt D; Kloeters-Plachky P; Rost D; Kulaksiz H; Stiehl A
    J Hepatol; 2010 Aug; 53(2):313-7. PubMed ID: 20472317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
    Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
    Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK; Nasioulas G; Kosmidis PA
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
    Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Rao BB; Lashner B; Kowdley KV
    Inflamm Bowel Dis; 2018 Jan; 24(2):269-276. PubMed ID: 29361103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal neoplasia in PSC-IBD patients: are times changing?
    Sokol H; Chazouilleres O
    Liver Int; 2012 Feb; 32(2):175-6. PubMed ID: 22226230
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature.
    Wang R; Leong RW
    World J Gastroenterol; 2014 Jul; 20(27):8783-9. PubMed ID: 25083052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune-mediated diseases in primary sclerosing cholangitis.
    Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK
    Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.